{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:33:50Z","timestamp":1782488030280,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.autrev.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T06:02:30Z","timestamp":1380175350000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1"],"prefix":"10.1016","volume":"13","author":[{"given":"Wolfgang","family":"Schlumberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Hornig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"D\u00e4hnrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.09.005_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: recent advances and future challenges","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.2010.34","article-title":"Membranous nephropathy: recent travels and new roads ahead","volume":"77","author":"Beck","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0015","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00108-003-1022-5","article-title":"Membranous glomerulonephritis","volume":"44","author":"Scheidat","year":"2003","journal-title":"Internist"},{"key":"10.1016\/j.autrev.2013.09.005_bb0020","first-page":"28","article-title":"L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking\u2014or were they?","volume":"17","author":"Steinman","year":"2003","journal-title":"Nephrol News Issues"},{"key":"10.1016\/j.autrev.2013.09.005_bb0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ndt\/gfp665","article-title":"Membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian population","volume":"25","author":"McQuarrie","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2013.09.005_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000348472","article-title":"Pathogenesis of membranous nephropathy: a new paradigm in evolution","volume":"181","author":"Glassock","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0035","first-page":"186","article-title":"KDIGO clinical practise guideline for glomerulonephritis","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis work group","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.autrev.2013.09.005_bb0040","series-title":"Renal diseases","first-page":"141","author":"Bell","year":"1946"},{"key":"10.1016\/j.autrev.2013.09.005_bb0045","first-page":"313","article-title":"Nephrotic glomerulonephritis","volume":"33","author":"Jones","year":"1957","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.106.2.191","article-title":"Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction","volume":"106","author":"Mellors","year":"1957","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0055","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0060","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI109248","article-title":"Experimental glomerulonephritis in the isolated perfused rat kidney","volume":"62","author":"Couser","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.09.005_bb0065","first-page":"502","article-title":"Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis","volume":"38","author":"Van Damme","year":"1978","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2013.09.005_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1980.1","article-title":"In situ immune complex formation and glomerular injury","volume":"17","author":"Couser","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0075","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.157.2.667","article-title":"Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats","volume":"157","author":"Kerjaschki","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.166.1.109","article-title":"Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane","volume":"166","author":"Kerjaschki","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0085","first-page":"500","article-title":"Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli I. Renal distribution","volume":"122","author":"Chatelet","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0090","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.09.005_bb0100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(04)17154-7","article-title":"Pathomechanisms and molecular basis of membranous glomerulopathy","volume":"364","author":"Kerjaschki","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.09.005_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-6147(99)01300-0","article-title":"Receptors for a growing family of secreted phospholipases A2","volume":"20","author":"Lambeau","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2013.09.005_bb0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0304-4165(02)00319-7","article-title":"The mannose receptor family","volume":"1572","author":"East","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2013.09.005_bb0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1074\/jbc.271.1.250","article-title":"Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2","volume":"271","author":"Zvaritch","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.09.005_bb0125","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00018-007-7497-9","article-title":"Extended and bent conformations of the mannose receptor family","volume":"65","author":"Llorca","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2013.09.005_bb0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MNH.0b013e32835026ed","article-title":"Membranous nephropathy: the start of a paradigm shift","volume":"21","author":"Herrmann","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.autrev.2013.09.005_bb0140","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/ndt\/gfr336","article-title":"New insights into membranous glomerulonephritis: from bench to bedside","volume":"26","author":"Murtas","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2013.09.005_bb0145","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0150","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jprot.2011.05.021","article-title":"Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens","volume":"74","author":"Bruschi","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.autrev.2013.09.005_bb0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.autrev.2006.10.004","article-title":"Alpha-enolase: a target of antibodies in infectious and autoimmune diseases","volume":"6","author":"Terrier","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.005_bb0160","first-page":"7","article-title":"Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library","author":"Cavazzini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2013.09.005_bb0165","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4049\/jimmunol.1003451","article-title":"Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis","volume":"187","author":"Meyer-Schwesinger","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.ki.5002450","article-title":"A new mouse model of immune-mediated podocyte injury","volume":"72","author":"Meyer","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0175","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0180","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2009121220","article-title":"Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy","volume":"21","author":"Ronco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","article-title":"IgG4 breaking the rules","volume":"105","author":"Aalberse","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2013.09.005_bb0195","first-page":"415","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0200","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ki.1986.198","article-title":"Immunohistochemical study of the C5b-9 complex of complement in human kidneys","volume":"30","author":"Hinglais","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0205","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ki.1992.143","article-title":"Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy","volume":"41","author":"Brenchley","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0210","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1681\/ASN.2012101023","article-title":"Monoclonal anti-PLA2R and recurrent membranous nephropathy: another piece of the puzzle","volume":"23","author":"Beck","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0215","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/oxfordjournals.ndt.a027450","article-title":"Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis","volume":"11","author":"Lhotta","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2013.09.005_bb0220","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","article-title":"An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis","volume":"26","author":"Hoxha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2013.09.005_bb0225","first-page":"269","article-title":"Rational histochemical analysis by means of a new microanalytical method","volume":"31","author":"St\u00f6cker","year":"1985","journal-title":"Acta Histochem Suppl"},{"key":"10.1016\/j.autrev.2013.09.005_bb0230","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cca.2013.03.015","article-title":"Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy","volume":"421","author":"D\u00e4hnrich","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2013.09.005_bb0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.ajkd.2011.10.044","article-title":"Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis","volume":"59","author":"Gunnarsson","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2013.09.005_bb0245","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0250","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0255","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2013.09.005_bb0260","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrneph.2013.125","article-title":"Treatment of idiopathic membranous nephropathy","volume":"9","author":"Hofstra","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0270","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/j.1600-6143.2009.02851.x","article-title":"Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.autrev.2013.09.005_bb0275","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1600-6143.2011.03643.x","article-title":"Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy","volume":"11","author":"Debiec","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.autrev.2013.09.005_bb0280","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/TP.0b013e31828a947b","article-title":"Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy","volume":"95","author":"Larsen","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2013.09.005_bb0285","first-page":"109","article-title":"Anti-PLA(2)R antibodies in membranous nephropathy: ready for routine clinical practice?","volume":"70","author":"Hofstra","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMc1011678","article-title":"PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.09.005_bb0295","first-page":"8","article-title":"An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor","author":"Behnert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2013.09.005_bb0300","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-013-2574-9","article-title":"Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy","author":"Cossey","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0305","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/modpathol.2012.207","article-title":"Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies","volume":"26","author":"Larsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.autrev.2013.09.005_bb0310","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/ndt\/gfs439","article-title":"Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy","volume":"28","author":"Svobodova","year":"2013","journal-title":"Nephrol Dial Transplant"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T13:53:31Z","timestamp":1539352411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1568997213001699"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.09.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}